{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Pharmaceuticals are racing to develop first drugs for celiac disease, condition that is now understood to be far more common than previously thought; drugs, which will not reach market until at least 2018, would not eliminate need for gluten-free diet, but could alleviate symptoms from trace elements; Food and Drug Admin is moving to develop standards for measuring drugs' effectiveness.", "type_of_material": "News", "word_count": "1426", "lead_paragraph": "It&#8217;s estimated that about three million Americans have celiac disease. And even though a gluten-free diet can help alleviate symptoms, it&#8217;s not a cure-all.", "pub_date": "2015-04-29T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "As Celiac and Gluten Sensitivities Gain Prominence, Drug Companies Race to Find Treatments", "print_headline": "Treating Celiac Disease"}, "snippet": "It&#8217;s estimated that about three million Americans have celiac disease. And even though a gluten-free diet can help alleviate symptoms, it&#8217;s not a cure-all.", "multimedia": [{"height": 126, "url": "images/2015/04/28/business/29gluten-web1/29gluten-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/04/28/business/29gluten-web1/29gluten-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/04/28/business/29gluten-web1/29gluten-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/04/28/business/29gluten-web1/29gluten-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/04/28/business/29gluten-web1/29gluten-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/04/28/business/29gluten-web1/29gluten-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/04/29/business/celiac-diseases-prominence-has-drug-companies-racing-to-find-treatments.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Gluten", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Celiac Disease", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "AbbVie Inc", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Avalon Ventures Limited", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Alvine Pharmaceuticals Inc", "name": "organizations"}, {"rank": "9", "is_major": "N", "value": "Sitari Pharmaceuticals Inc", "name": "organizations"}], "blog": [], "_id": "553ff2f438f0d877377da0eb", "source": "The New York Times"}